Literature DB >> 22884670

Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics.

Sjoerd C Bruggink1, Maurits N C de Koning, Jacobijn Gussekloo, Paulette F Egberts, Jan Ter Schegget, Mariet C W Feltkamp, Jan Nico Bouwes Bavinck, Wim G V Quint, Willem J J Assendelft, Just A H Eekhof.   

Abstract

BACKGROUND: Epidemiological data on cutaneous wart-associated HPV types are rare.
OBJECTIVES: To examine the prevalence of cutaneous wart-associated HPV types and their relation with patient characteristics. STUDY
DESIGN: Swabs were taken from all 744 warts of 246 consecutive immunocompetent participants and analysed by a broad spectrum HSL-PCR/MPG assay. Patient details including location, duration, and number of warts were recorded.
RESULTS: No HPV DNA was detected in 49 (7%) swabs, a single HPV type in 577 (78%) swabs, and multiple HPV types in 118 (16%) swabs. HPV 2, 27 and 57 (alpha genus), HPV 4 (gamma genus) and HPV 1 (mu genus) were the most frequently detected HPV types, and HPV 63 (mu genus) was only frequently detected together with other HPV types. Less frequently detected HPV types were HPV 3, 7, 10 and 28 (alpha genus), 65, 88 and 95 (gamma genus) and 41 (nu genus). Warts containing HPV 1 showed the most distinct clinical profile, being related to children aged <12 years, plantar location, duration <6 months, and to patients with <4 warts.
CONCLUSIONS: HPV 27, 57, 2 and 1 are the most prevalent HPV types in cutaneous warts in general population. Warts infected with HPV 1 have a distinct clinical profile.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22884670     DOI: 10.1016/j.jcv.2012.07.014

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  31 in total

1.  Prevalence of HPV Genotypes in Adult Male Patients with Cutaneous Warts: A Cross-Sectional Study.

Authors:  Rana Al-Awadhi; Nawaf Al-Mutairi; Wassim Chehadeh
Journal:  Med Princ Pract       Date:  2019-12-25       Impact factor: 1.927

2.  Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.

Authors:  Guneet Awal; Simplepreet Kaur
Journal:  J Clin Aesthet Dermatol       Date:  2018-05-01

Review 3.  HPV vaccination for prevention of skin cancer.

Authors:  Sabrina E Vinzón; Frank Rösl
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Efficacy of pulsed dye laser treatment for common warts is not influenced by the causative HPV type: a prospective study.

Authors:  Yoseph Fichman; Assi Levi; Emmilia Hodak; Shlomit Halachmi; Sigal Mazor; Dana Wolf; Orit Caplan; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2017-12-07       Impact factor: 3.161

5.  Topical ionic contra-viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts.

Authors:  T van der Kolk; M R Dillingh; R Rijneveld; E S Klaassen; M N C de Koning; S T P Kouwenhoven; R E Genders; J N Bouwes Bavinck; G Feiss; R Rissmann; J Burggraaf
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-09-06       Impact factor: 6.166

6.  Molecular characterization, tissue tropism, and genetic variability of the novel Mupapillomavirus type HPV204 and phylogenetically related types HPV1 and HPV63.

Authors:  Anja Šterbenc; Lea Hošnjak; Diego Chouhy; Elisa M Bolatti; Anja Oštrbenk; Katja Seme; Boštjan J Kocjan; Boštjan Luzar; Adriana A Giri; Mario Poljak
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

7.  Comparative Clinical Efficacy between Electrodesiccation with Curettage and Application of 80% Phenol Solution in Treatment of Common Warts.

Authors:  Dina Arwina Dalimunthe; Remenda Siregar; Chairiyah Tanjung
Journal:  Open Access Maced J Med Sci       Date:  2018-02-11

Review 8.  Human Papilloma Virus Vaccination.

Authors:  Kendal Rosalik; Christopher Tarney; Jasmine Han
Journal:  Viruses       Date:  2021-06-08       Impact factor: 5.048

9.  Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types.

Authors:  Xue Chen; Hongyang Liu; Zhirong Wang; Shuo Wang; Ting Zhang; Meili Hu; Liang Qiao; Xuemei Xu
Journal:  Oncotarget       Date:  2017-07-18

Review 10.  Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?

Authors:  Daniel Hasche; Sabrina E Vinzón; Frank Rösl
Journal:  Front Microbiol       Date:  2018-05-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.